Results 91 to 100 of about 3,199 (178)

Short Dynamic 68 GA-PSMA PET Reconstruction to Differentiate Urinary Excretion From Extra-urinary Uptakes With LAFOV-PET. [PDF]

Clin Nucl Med
Delhom L, Bourhis D, Delcroix O, Robin P, Querellou S.   +4 more
europepmc   +1 more source

STUDIES ON CLINICAL BACK-GROUND FACTORS IN BREST CANCER AND MASTOPATHY

The journal of the Japanese Practical Surgeon Society, 1984
YUGE, Shizuhiko, FUKUSHIMA, Takashi, HONDA, Tetuya, TSUCHIDA, Isamu, FUJIMASA, Atushi, UEDA, Masanobu, KAN, Sadayuki, UTIYAMA, Maki, OKU, Hiroshi, SOU, Mituo, EDAKUNI, Setuo, WATANABE, Keiji   +11 more
openaire   +2 more sources

Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study. [PDF]

J Immunother Cancer
Tison A, Jannat-Khah D, Cappelli LC, Suarez-Almazor ME, Abdel-Wahab N, Reid P, Sparks JA, Braaten TJ, Meara A, Calabrese C, Katsumoto T, Ghosh N, Ge K, Saraux A, Devauchelle-Pensec V, Shah AA, Bingham CO, Bass AR.   +17 more
europepmc   +1 more source

Investigation to the Screening Methods of Brest Cancer in MHTS

Japanese journal of MHTS, 1990
openaire   +2 more sources

Case Report: long complete metabolic response assessed by LAFOV FDG-PET/CT to FOLFIRINOX in first-line treatment of metastatic low-differentiated pancreatic carcinoma. [PDF]

Front Med (Lausanne)
Abgral R, Dzuko Kamga J, Metges JP, Salaun PY.   +3 more
europepmc   +1 more source

Cancer screening in patients with severe psychiatric disorders in France: Towards a coordinated and inclusive approach. [PDF]

Eur J Gen Pract
Pellen N, Gouzien B, Troënes M, Khelifi S, Ragot G, Le Glaz A.   +5 more
europepmc   +1 more source

Physiotherapy in brest cancer: life quality and function clinical evolution

Ciência & Saúde, 2011
Gabriela Tomedi Leites, Mara Regina Knorst, Caroline Helena Lazzarotto De Lima, Felipe Pereira Zerwes, Verônica Baptista Frison   +4 more
openaire   +2 more sources

¹⁸F-FDG PET radiomic analysis to predict outcomes in metastatic melanoma treated with immune checkpoint inhibitors. [PDF]

Front Immunol
Amrane K, Le Meur C, Bourhis D, Berthou C, Pradier O, Misery L, Legoupil D, Etienne M, Fontaine GP, Leleu C, Floch R, Salaun PY, Abgral R, Bourbonne V.   +13 more
europepmc   +1 more source

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies

Frontiers in Pharmacology, 2020
Diana Gulei, Ciprian Tomuleasa, Ciprian Tomuleasa, Liren Qian, Cristina Bagacean, Cristina Bagacean, Carlo M. Croce, Gabriel Ghiaur   +7 more
doaj   +1 more source

Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings. [PDF]

JTO Clin Res Rep
Delva F, Gendarme S, Boudet L, Zysman M, Fuhrman C, Brillet PY, Brochard P, Paris C, Bylicki O, Le Denmat V, Loddé B, Belacel M, Abdessemed N, Despagne M, Jaunas K, Lacourt A, Clin B, Gehanno JF, Laurent F, Dournes G, Mathoulin-Pélissier S, Chouaïd C, Pairon JC.   +22 more
europepmc   +1 more source